SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Overview** Sage Therapeutics is searching for a creative, resourceful, innovative thinker to support a new Digital Health function. He/ She is responsible to source, develop and apply transformative digital technologies and advanced data ...
Posted: April 18, 2018, 7:20 am
**Overview** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible andaccountable for Data Management activities that support developme...
Posted: April 18, 2018, 7:20 am
**Overview** **General Scope and Summary** Sage Therapeutics () is searching highly-motivated, resourceful, technical thinker to join our growing Finance team.The Senior Accountant will be a key member of the finance team. This posit...
Posted: April 14, 2018, 9:54 am
**Overview** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is a key player in supporting and streamlining our sales and marketing operations. This position will function under the...
Posted: April 14, 2018, 8:56 am
**Overview** **General Scope and Summary** Sage Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible for complete business ownership of Regional Trade Accounts. This per...
Posted: April 11, 2018, 8:12 am

Viewing page 1 of 21|Next Page

  Newsfeed | Subscribe  

Shares of Stanley Black & Decker fell nearly 7% after the toolmaker reported its first-quarter financial results. At first glance, the company seemed to do reasonably well, posting 12% revenue growth and a 7% rise in adjusted earnings per share. H...
Posted: April 20, 2018, 1:48 pm
SAGE Therapeutics (SAGE-7.4%) slumps on below-average volume. Investors apparently perceive diminished prospects for a deal with Biogen on the heels of its $1B deal with Ionis. Previously: Ionis up 8% premarket on new $1B 10-year collaboration wit...
Posted: April 20, 2018, 11:36 am
Sage Therapeutics (NASDAQ: SAGE) a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that data from clinical studies of its proprietary i.v. formulati...
Posted: April 17, 2018, 1:01 pm
Central Securities Corp decreased its stake in Encore Cap Group Inc (ECPG) by 50% based on its latest 2017Q4 regulatory filing with the SEC. Central Securities Corp sold 100,000 shares as the company’s stock rose 3.58% while stock markets declined...
Posted: April 12, 2018, 10:21 pm
Sage Therapeutics Inc. (SAGE) traded on unusually high volume on Apr. 11, as the stock lost 1.39% to close at $167.02. On the day, Sage Therapeutics Inc. saw 776,951 shares trade hands on 8,838 trades. Considering that the stock averages only a da...
Posted: April 11, 2018, 11:15 pm

Viewing page 1 of 2|Next Page